Related Experiment Video
Updated: May 27, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
[Current strategy for management of resistant hypertension]
Tetsutaro Matayoshi1, Yusuke Oya
1Center of Residency and Fellowship Program, University of the Ryukyus Hospital.
Abstract:
Inadequate control of blood pressure during antihypertensive treatment remains a major problem in preventive cardiovascular and renal disease. Major causes of resistant hypertension are following: problems in measuring technique, presence of white coat effect, poor adherence of patient, obesity, excessive alcohol intake, sleeping apnea syndrome, excess of body fluid, inappropriate use of hypertensive or anti-antihypertensive drug/supplement, especially their combination, and presence of secondary hypertension. Practitioners have to seek for the causes around their patients' lifestyle, prescription, secondary hypertension, after ruling out pseudo-hypertension or white coat hypertension. Evaluation of complications is also important in management of resistant cases, because of their high prevalence of target organ damage.
Related Concept Videos
Heart Failure V: Medical Management
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension V: Nursing Management
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Atherosclerosis III: Management
Rheumatic Heart Disease III: Medical Management